Inhibrx

+$0.98 (+7.82%) Today
$0.00 (0.00%) As of 8:20 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Inhibrx and other ETFs, options, and stocks.

About INBX

Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases.

CEO
Mark P. Lappe
Employees
112
Headquarters
La Jolla, California
Founded
2010

INBX Key Statistics

Market cap
527.39M
Price-Earnings ratio
—
Dividend yield
—
Average volume
720.87K
High today
$13.53
Low today
$12.36
Open price
$12.88
Volume
575.58K
52 Week high
$47.90
52 Week low
$11.56

INBX Earnings

-$0.80
-$0.53
-$0.27
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.80 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure